The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies.

Objectives: To identify the main cost components included in the economic evaluations of measles outbreaks, their items and cost drivers, and evaluate the quality of costing methodology, analyzing the key features that may affect the validity of these studies in countries with different income levels.

Methods: We systematically searched multiple databases EMBASE, MEDLINE (via PubMed), Biblioteca Virtual em Saúde do Ministério da Saúde (BVS MS), NHS Economic Evaluation Database (NHS EED) and NHS Health Technology Assessment (NHS HTA) (via The Centre for Reviews and Dissemination Library - CRD), and EconLit, SCOPUS, and Web of Science, selecting cost analysis and cost of illness studies (COI) of measles outbreaks. Two independent reviewers screened articles for relevance and extracted the data.

[Culicidae (Diptera) in the dam area bordering the states of Santa Catarina and Rio Grande do Sul, Brazil].

The Culicidae composition of the Barra Grande Lake situated between the municipalities of Esmeralda (Rio Grande do Sul State) and Anita Garibaldi (Santa Catarina State) was assessed by monthly samplings. Twenty-four species were identified from a total of 1,185 specimens (74.7% as adults and 25.

Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelin.

Objective: To identify the genes presenting different expression in uterine leiomyomas after goserelin treatment.

Design: Retrospective analyses of tissue obtained in a prospective clinical study.

Setting: School of Medicine of the University of São Paulo.

Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.

Objective: To assess the effect of the aromatase inhibitor on patients with leiomyoma in the reproductive stage regarding reduction of uterine volume and control of symptoms.

Design: Clinical study.

Setting: Academic clinical practice.

Comparative study of different dosages of goserelin in size reduction of myomatous uteri.

Study Objective: To compare uterine size reduction obtained with three monthly subcutaneous injections of 3.6 mg of goserelin versus a single subcutaneous injection of 10.8 mg.